Q&A The Lost Poetry of Patient Stories Medical histories capture a vital snapshot of a patient’s health status. In his new book, hematologist-oncologist Mikkael A. Sekeres provides a richer narrative. by Marci A. Landsmann Keeping CLL in Check With recent advances in targeted treatments, people diagnosed with chronic lymphocytic leukemia have more options to manage the disease. by Kendall K. Morgan Get Involved Filling a Void A mother whose son was diagnosed with Burkitt leukemia works to improve access to mental health services for teenagers. by Elizabeth Rosto Sitko Despite Generic Imatinib, Cost of Treating CML Remains High The arrival of generic versions of the targeted therapy imatinib only modestly reduced the cost of treating chronic myelogenous leukemia patients, a study finds. by Anna Azvolinsky When Cancer Becomes an Unwanted Priority Amanda Rose Ferraro’s leukemia diagnosis forced her to spend time at the hospital away from her 3-year-old-son. She calls focusing on her health and leaving her son “the hardest thing I have ever had to do.” by Amanda Rose Ferraro Clinical Trials: An African American Survivor’s Experience Melvin Mann benefited from joining a pivotal clinical trial for chronic myelogenous leukemia, but participation came with logistical challenges. by Melvin Mann Finding More Targets for CAR-T Cells CAR-T cell therapy has successfully treated some patients with leukemia and lymphoma. Researchers are looking to expand the range of cancers that will respond to the therapy. by Kendall K. Morgan FROM THE EDITOR-IN-CHIEF Clonal Hematopoiesis: You Are Not the Same Person You Used to Be DNA sequencing of blood cells may provide clues for how cancer and other illnesses develop. by William G. Nelson, MD, PhD FORWARD LOOK Pediatric Leukemia Treatments Are Not Just for Kids Study supports using these regimens for teens and young adults. by Bradley Jones FROM THE EDITOR-IN-CHIEF CAR-T Cells: ‘Bionic’ Immune Cells for Treating Cancer T cells are being rebuilt to kill cancer cells. by William G. Nelson, MD, PhD next Cancer Talk Cancer Centers Cope With COVID-19 Surge Doctors at cancer centers in states with record COVID-19 hospitalization rates reflect on how lessons from early in the pandemic are helping them care for patients during the current surge. by Ashley P. Taylor Why Do African Americans Have Increased Breast Cancer Mortality? Socioeconomic factors and racism can lead to poorer health outcomes for Black Americans. Genetics may also be a factor behind increased mortality rates. by Marci A. Landsmann Liquid Biopsies May Ease Enrollment in Clinical Trials A study shows that a blood test for gastrointestinal tumor mutations gave results in a third of the time needed for solid tissue testing. Patients who received the blood test were more likely to enroll in clinical trials. by Emma Yasinski What Is Tumor Mutational Burden? The Food and Drug Administration approved an immunotherapy drug for tumors with high tumor mutational burden regardless of tumor type. But some medical oncologists say it’s not clear the biomarker is valid across all cancer types. by Anna Azvolinsky More Posts